This funding opportunity encourages research to develop novel screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also targets high priority genetic conditions where screening is not yet recommended but early identification and treatment would be beneficial. The goal is to improve screening accuracy and demonstrate the benefits of early intervention or treatment to support inclusion on newborn screening panels.
Eligible applicants include a wide range of U.S. entities such as city, county, state, and tribal governments, nonprofits (both 501(c)(3) and others), institutions of higher education, small businesses, and for-profit organizations. Specific eligibility details should be confirmed with the funding o
